Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Elevated type I interferon-like activity in a subset of multiple sclerosis patients: molecular basis and clinical relevance.
Atorvastatin Added to Interferon Beta for Relapsing Multiple Sclerosis: 12-Month Treatment Extension of the Randomized Multicenter SWABIMS Trial.
Neither T-helper type 2 nor Foxp3+ regulatory T cells are necessary for therapeutic benefit of atorvastatin in treatment of central nervous system autoimmunity.
Multiple sclerosis susceptibility in a Brazilian sample, HLA and CIITA genes.
The squares test as a measure of hand function in multiple sclerosis.
Functional relevance for multiple sclerosis-associated genetic variants.
Silent aspiration and recovery from Dysphagia in a case of bickerstaff brainstem encephalitis.
Gait disorders in multiple sclerosis.
Impaired decision-making and diffusion orientational complexity in people with multiple sclerosis.
Reduced grey matter perfusion without volume loss in early relapsing-remitting multiple sclerosis.
Correction: Adipocytokine Profile, Cytokine Levels and Foxp3 Expression in Multiple Sclerosis: a Possible Link to Susceptibility and Clinical Course of Disease.
Long-term efficacy of Gilenya® reinforced by new 'no evidence of disease activity' (NEDA-4) analysis in MS patients over seven years
How does magnetization transfer influence mcDESPOT results?
Clinical assessment and management of sleep disorders in multiple sclerosis: a literature review.
Post subthalamic area deep brain stimulation for tremors: a mini-review.
International Pediatric MS Study Group Clinical Trials Summit: Meeting report.
Computer-based diagnosis of illness in historical persons.
The primary vascular dysregulation syndrome: implications for eye diseases.
Disease-specific therapy of idiopathic inflammatory demyelinating disorders.
Using the random forest method to detect a response shift in the quality of life of multiple sclerosis patients: a cohort study.
Multiple sclerosis: Linking disability and spinal cord imaging outcomes in MS.
Potential Beneficial Effects of Marine Peptide on Human Neuron Health.
Simvastatin Treatment of Patients With Acute Optic Neuritis
Corneal Sensitivity and Tear Function in Neurodegenerative Diseases.
Relationship between contrast sensitivity test and disease severity in multiple sclerosis patients.
Pages
« first
‹ previous
…
364
365
366
367
368
369
370
371
372
…
next ›
last »